Literature DB >> 32814968

Colonization with multiresistant bacteria in acute hospital care: the association of prior antibiotic consumption as a risk factor.

Nasra Dualleh1, Iman Chanchiri1, Helene Skjøt-Arkil2,3, Andreas Kristian Pedersen3, Flemming S Rosenvinge4, Isik Somuncu Johansen1,5,6.   

Abstract

BACKGROUND: Antibiotic resistance poses a worldwide threat and knowledge concerning risk factors for colonization with multiresistant bacteria (MRB) is limited.
OBJECTIVES: To examine the impact of prior antibiotic consumption on MRB colonization, with focus on type of antibiotic and timeline between antibiotic prescription and MRB colonization.
METHODS: A nationwide case-control study was conducted and adults visiting emergency departments were invited to participate. All patients were swabbed in the throat, nose and rectum, and analysed for colonization with ESBL-producing Enterobacteriaceae (ESBL-E), MRSA, carbapenemase-producing enterobacteria and VRE. Antibiotic history 2 years prior to enrolment was collected at an individual level through a national register. Multivariate analyses were performed to examine the association between antibiotic consumption and MRB status. A subgroup analysis of ESBL-E-colonized cases was made.
RESULTS: We included 256 patients colonized with MRB and 4763 controls. In the 2 years prior to study inclusion, 77% of cases and 68% of controls had at least one antibiotic prescription (P = 0.002). We found a significant increase in risk of colonization with ESBL-E if penicillins (OR = 1.58-1.65) or fluoroquinolones (OR = 2.25-6.15) were prescribed. The analysis of all MRB-colonized patients showed similar results. An assessment of the timeline showed a significant increase in risk of colonization up to 2 years after exposure to penicillins, fluoroquinolones and macrolides.
CONCLUSIONS: The prevalence of ESBL-E colonization was related to fluoroquinolone, macrolide and penicillin consumption for at least 2 years after antibiotic treatment.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32814968     DOI: 10.1093/jac/dkaa365

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

1.  Risk factors for antibiotic-resistant bacteria colonisation in children with chronic complex conditions.

Authors:  Martin Agud; Ines de Medrano; Ana Mendez-Echevarria; Talia Sainz; Federico Román; Guillermo Ruiz Carrascoso; Luis Escosa-Garcia; Clara Molina Amores; Francisco José Climent; Aroa Rodríguez; Marta Garcia-Fernandez de Villalta; Cristina Calvo
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

2.  Economic burden attributable to healthcare-associated infections in tertiary public hospitals of Central China: a multi-centre case-control study.

Authors:  Peng Li; Yan Li; Youjian Zhang; Junzhe Bao; Ruixia Yuan; Hongwen Lan; Mingjie Sun
Journal:  Epidemiol Infect       Date:  2022-08-15       Impact factor: 4.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.